BIRDS

BIRDS

900 bookmarks
Custom sorting
The size and concentration of droplets generated by coughing in human subjects - PubMed
The size and concentration of droplets generated by coughing in human subjects - PubMed
This work investigated the size distribution of the droplet nuclei and coughed droplets by test subjects. The size distributions of droplet nuclei coughed by test subjects were determined with an aerodynamic particle sizer (APS) and scanning mobility particle sizer (SMPS) system (system 1). Coughed …
·pubmed.ncbi.nlm.nih.gov·
The size and concentration of droplets generated by coughing in human subjects - PubMed
The mechanism of breath aerosol formation - PubMed
The mechanism of breath aerosol formation - PubMed
The dependence of the particle concentration decay rate on diameter during breath holding was consistent with gravitational settling in the alveolar spaces. Also, deep exhalation resulted in a four- to sixfold increase in concentration, and rapid inhalation produced a further two- to threefold incre …
·pubmed.ncbi.nlm.nih.gov·
The mechanism of breath aerosol formation - PubMed
Exhaled breath condensate as a matrix for combustion-based nanoparticle exposure and health effect evaluation - PubMed
Exhaled breath condensate as a matrix for combustion-based nanoparticle exposure and health effect evaluation - PubMed
The use of diffusion light scattering for particle counting proved to be sufficiently sensitive to detect objects in EBC, but lacked the specificity for carbonaceous tobacco smoke particles. Our results suggest two phases of oxidation markers in EBC: first, the initial deposition of particles and ga …
·pubmed.ncbi.nlm.nih.gov·
Exhaled breath condensate as a matrix for combustion-based nanoparticle exposure and health effect evaluation - PubMed
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States - PubMed
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States - PubMed
Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological and virological characteristics are limited. In this case series, we describe the first 12 US patients confirmed to have COVID-19 from 20 January to 5 February 2020, including 4 patients described previously …
·pubmed.ncbi.nlm.nih.gov·
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States - PubMed
Indoor air quality in a middle school, Part II: Development of emission factors for particulate matter and bioaerosols - PubMed
Indoor air quality in a middle school, Part II: Development of emission factors for particulate matter and bioaerosols - PubMed
A middle school (grades 6 to 8) in a residential section of Springfield, Illinois, with no known air quality problems, was selected for a baseline indoor air quality survey. The study was designed to measure and evaluate air quality at the middle school with the objective of providing a benchmark fo …
·pubmed.ncbi.nlm.nih.gov·
Indoor air quality in a middle school, Part II: Development of emission factors for particulate matter and bioaerosols - PubMed
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoECDIQAQ&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fmedical%2Fmm_Future%2Fmm_0547_coveragepositioncriteria_implantable_electrocardiographic_event_monitors.pdf&usg=AOvVaw3coV7DXyvWz8lujEw4m3yd
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoECDIQAQ&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fmedical%2Fmm_Future%2Fmm_0547_coveragepositioncriteria_implantable_electrocardiographic_event_monitors.pdf&usg=AOvVaw3coV7DXyvWz8lujEw4m3yd
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoECDIQAQ&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fmedical%2Fmm_Future%2Fmm_0547_coveragepositioncriteria_implantable_electrocardiographic_event_monitors.pdf&usg=AOvVaw3coV7DXyvWz8lujEw4m3yd
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCNsBEAE&url=https%3A%2F%2Fwww.paramounthealthcare.com%2Fassets%2Fdocuments%2Fmedicalpolicy%2Fpg0039_cardiac_event_monitors_and_detection.pdf&usg=AOvVaw2LFU6iABP71ioywGagNdgK
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCNsBEAE&url=https%3A%2F%2Fwww.paramounthealthcare.com%2Fassets%2Fdocuments%2Fmedicalpolicy%2Fpg0039_cardiac_event_monitors_and_detection.pdf&usg=AOvVaw2LFU6iABP71ioywGagNdgK
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCNsBEAE&url=https%3A%2F%2Fwww.paramounthealthcare.com%2Fassets%2Fdocuments%2Fmedicalpolicy%2Fpg0039_cardiac_event_monitors_and_detection.pdf&usg=AOvVaw2LFU6iABP71ioywGagNdgK
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCLYCEAE&url=https%3A%2F%2Fwww.bluecrossma.org%2Fmedical-policies%2Fsites%2Fg%2Ffiles%2Fcsphws2091%2Ffiles%2Facquiadam-assets%2F347%2520Ambulatory%2520Event%2520Monitors%2520and%2520Mobile%2520Outpatient%2520Cardiac%2520Telemetry%2520prn.pdf&usg=AOvVaw04Zx-QAW2KydIdYW48HgaR
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCLYCEAE&url=https%3A%2F%2Fwww.bluecrossma.org%2Fmedical-policies%2Fsites%2Fg%2Ffiles%2Fcsphws2091%2Ffiles%2Facquiadam-assets%2F347%2520Ambulatory%2520Event%2520Monitors%2520and%2520Mobile%2520Outpatient%2520Cardiac%2520Telemetry%2520prn.pdf&usg=AOvVaw04Zx-QAW2KydIdYW48HgaR
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCLYCEAE&url=https%3A%2F%2Fwww.bluecrossma.org%2Fmedical-policies%2Fsites%2Fg%2Ffiles%2Fcsphws2091%2Ffiles%2Facquiadam-assets%2F347%2520Ambulatory%2520Event%2520Monitors%2520and%2520Mobile%2520Outpatient%2520Cardiac%2520Telemetry%2520prn.pdf&usg=AOvVaw04Zx-QAW2KydIdYW48HgaR
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCIYBEAE&url=https%3A%2F%2Fmatsusurgical.com%2Fwp-content%2Fuploads%2Fsites%2F450%2F2019%2F04%2FPrep-for-Esophageal-pH-Monitoring.pdf&usg=AOvVaw31eTfuwQIFLIrm4bcbHysU
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCIYBEAE&url=https%3A%2F%2Fmatsusurgical.com%2Fwp-content%2Fuploads%2Fsites%2F450%2F2019%2F04%2FPrep-for-Esophageal-pH-Monitoring.pdf&usg=AOvVaw31eTfuwQIFLIrm4bcbHysU
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCIYBEAE&url=https%3A%2F%2Fmatsusurgical.com%2Fwp-content%2Fuploads%2Fsites%2F450%2F2019%2F04%2FPrep-for-Esophageal-pH-Monitoring.pdf&usg=AOvVaw31eTfuwQIFLIrm4bcbHysU
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCJoBEAE&url=https%3A%2F%2Fwww.amerihealthcaritaspa.com%2Fpdf%2Fprovider%2Fresources%2Fclinical%2Fpolicies-20201214%2Fccp1337-continuous-ambulatory-electrocardiography-patch-monitoring.pdf&usg=AOvVaw1PNhLxIN0z6WBieg21epLx
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCJoBEAE&url=https%3A%2F%2Fwww.amerihealthcaritaspa.com%2Fpdf%2Fprovider%2Fresources%2Fclinical%2Fpolicies-20201214%2Fccp1337-continuous-ambulatory-electrocardiography-patch-monitoring.pdf&usg=AOvVaw1PNhLxIN0z6WBieg21epLx
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjO3JSM8uLyAhXyY98KHRyeBfkQFnoFCJoBEAE&url=https%3A%2F%2Fwww.amerihealthcaritaspa.com%2Fpdf%2Fprovider%2Fresources%2Fclinical%2Fpolicies-20201214%2Fccp1337-continuous-ambulatory-electrocardiography-patch-monitoring.pdf&usg=AOvVaw1PNhLxIN0z6WBieg21epLx
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjC8e_68uLyAhWDg-AKHe0bCp04ZBAWegQIBhAB&url=http%3A%2F%2Fcedarvalleygi.com%2Fwp-content%2Fuploads%2F2015%2F04%2FUnityPoint-AmbulatoryImpedance-PatientEd-Form.pdf&usg=AOvVaw0qyvqxctYW5ehd74yCk1f8
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjC8e_68uLyAhWDg-AKHe0bCp04ZBAWegQIBhAB&url=http%3A%2F%2Fcedarvalleygi.com%2Fwp-content%2Fuploads%2F2015%2F04%2FUnityPoint-AmbulatoryImpedance-PatientEd-Form.pdf&usg=AOvVaw0qyvqxctYW5ehd74yCk1f8
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjC8e_68uLyAhWDg-AKHe0bCp04ZBAWegQIBhAB&url=http%3A%2F%2Fcedarvalleygi.com%2Fwp-content%2Fuploads%2F2015%2F04%2FUnityPoint-AmbulatoryImpedance-PatientEd-Form.pdf&usg=AOvVaw0qyvqxctYW5ehd74yCk1f8
Antilipemic Agent Bile Acid Sequestrants - StatPearls - NCBI Bookshelf
Antilipemic Agent Bile Acid Sequestrants - StatPearls - NCBI Bookshelf
Bile acid sequestrants are FDA-approved to manage hypercholesterolemia. They can be used in combination with HMG-CoA reductase inhibitors (statins) or used as monotherapy. Often bile acid sequestrants are used as adjuvant therapy to complement exercise and dietary modifications. This activity discusses their indications, mechanism of action, adverse effects, contraindications, and administration to lower LDL- cholesterol.
·ncbi.nlm.nih.gov·
Antilipemic Agent Bile Acid Sequestrants - StatPearls - NCBI Bookshelf
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwip_eLgj-PyAhVqRzABHUIdCpQQFnoFCJYCEAE&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fcnf%2Fcnf_041_coveragepositioncriteria_bile_acid_sequestrants_st.pdf&usg=AOvVaw0HStA0NuyXNpOVH3bQBgkN
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwip_eLgj-PyAhVqRzABHUIdCpQQFnoFCJYCEAE&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fcnf%2Fcnf_041_coveragepositioncriteria_bile_acid_sequestrants_st.pdf&usg=AOvVaw0HStA0NuyXNpOVH3bQBgkN
·google.com·
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwip_eLgj-PyAhVqRzABHUIdCpQQFnoFCJYCEAE&url=https%3A%2F%2Fstatic.cigna.com%2Fassets%2Fchcp%2Fpdf%2FcoveragePolicies%2Fcnf%2Fcnf_041_coveragepositioncriteria_bile_acid_sequestrants_st.pdf&usg=AOvVaw0HStA0NuyXNpOVH3bQBgkN
Appropriate Use of Ceftriaxone in the Emergency Department of a Veteran’s Health Care System
Appropriate Use of Ceftriaxone in the Emergency Department of a Veteran’s Health Care System
Background: Ceftriaxone is a third-generation cephalosporin commonly utilized as an empiric antibiotic treatment option in the emergency department (ED). Overuse can lead to decreased susceptibility and emergence of multidrug-resistant pathogens, increased ...
·ncbi.nlm.nih.gov·
Appropriate Use of Ceftriaxone in the Emergency Department of a Veteran’s Health Care System
ceftriaxone (CHEBI:29007)
ceftriaxone (CHEBI:29007)
Chemical Entities of Biological Interest (ChEBI) is a freely available dictionary of molecular entities focused on 'small' chemical compounds.
·ebi.ac.uk·
ceftriaxone (CHEBI:29007)
Pharmaceutical Contract Development & Manufacturing Organization (CDMO) | Piramal Pharma Solutions
Pharmaceutical Contract Development & Manufacturing Organization (CDMO) | Piramal Pharma Solutions
Contract Development & Manufacturing Pharmaceutical company (CDMO) - Piramal Pharma Solutions, one of the leading pharmaceutical manufacturing companies in India established in 1984, offering contract manufacturing services covering drug life cycle from drug discovery to development. Contact us for further details.
·piramalpharmasolutions.com·
Pharmaceutical Contract Development & Manufacturing Organization (CDMO) | Piramal Pharma Solutions